low glutathione diseases Frontiers Causes of Low Glutathione Levels

G.|Chen, J.|Zhang, Y.|Worden, L.|Freed, W

doi: 10.3389/fphar.2025.1639698 Received 02 June 2025 Revised 11 October 2025 Accepted 20 October 2025 Published 21 November 2025 Volume 16 - 2025 Edited by Maria Yelshanskaya, Columbia University, United States Reviewed by Linda Marie Nowak, Cornell University, United States Yue Zeng, Chinese Academy of Sciences (CAS), China Updates Copyright 2025 Garca-Daz, Castellanos, Miguez-Cabello, Picaol, Prez-Gonzlez, Gratacs-Batlle, Vega-Castro, Altafaj, Reyes-Guzmn, Reyes-Montao, Gasull and Soto

This highlights the potential of these agents as a viable therapeutic option for melasma management, addressing both aesthetic concerns and underlying hormonal factors

For Kd estimation, a slow-exchange binding model was utilized, allowing for the evaluation of residue-specific isotherm curves by tracking changes in peak intensity during the titration

The 600mg dose is split across the bilayer, and the tablet form allows for this controlled delivery mechanism that standard capsules cannot replicate

The causative factors contributing to the onset and development of complex and multigenic neurodegenerative diseases have been attributed to genetic and environmental factors (Brown et al